Frank Feigenbaum

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

James M. Markert, Michael D. Medlock, Samuel D. Rabkin et al. · Gene Therapy · 2000 · 971 citations

Neuro-oncology, Cancer-associated Virus, Glioma +8

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

William D. Hunter, Robert L. Martuza, Frank Feigenbaum et al. · Journal of Virology · 1999 · 191 citations · Full text

Viral Shedding and Biodistribution of G207, a MuItimutated, Conditionally Replicating Herpes Simplex Virus Type 1, after Intracerebral Inoculation in Aotus

Tomoki Todo, Frank Feigenbaum, Samuel D. Rabkin et al. · Molecular Therapy · 2000 · 92 citations · Full text

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

S-I Miyatake, Shoichi Tani, Frank Feigenbaum et al. · Gene Therapy · 1999 · 71 citations

Cancer-associated Virus, Viral Persistence, Immunology +11

Intraoperative Computed Tomography for Complex Craniocervical Operations and Spinal Tumor Resections

Barbara Hum, Frank Feigenbaum, Kevin Cleary et al. · Neurosurgery · 2000 · 42 citations